Abstract:Persistent high-risk human papillomavirus (HPV) infection is the major causal factor in cervical and other anogenital cancers. Because there are currently no therapeutics capable of preventing neoplastic progression of HPV infections, understanding the mechanisms of HPV-mediated persistence, including immune evasion, is a major research priority. The multifunctional growth factor transforming growth factor beta (TGFβ) has been shown to inhibit expression of early viral transcripts from cells harboring integrated HPV genomes or cells infected with retroviruses expressing HPV oncoproteins. However, the mechanism of TGFβ-induced inhibition has not been fully defined. In this study, we have observed a previously uncharacterized ability of TGFβ to repress the differentiation-induced upregulation of late HPV16 gene expression. In addition, interferon kappa (IFN-κ), a keratinocyte-specific, constitutively expressed cytokine suppressed by differentiation, can be transcriptionally induced by TGFβ1. TGFβ-mediated IFN-κ transcription only occurs in cells containing HPV16, and this is due to TGFβ1-mediated reversal of HPV-induced methylation of the IFN-κ promoter through active DNA demethylation mediated by thymine DNA glycosylase (TDG). This novel interaction between growth factor and innate immune signaling may shed light on the mechanisms of HPV persistence and how the virus manipulates both immune and growth factor signaling to promote its life cycle.IMPORTANCE Persistent infection by high-risk HPVs is the primary risk factor for development of HPV-induced cancers. Persistence involves viral evasion of the immune response, including the IFN response. HPV is also known to suppress TGFβ signaling, which inhibits viral gene expression. Here, we show that the TGFβ and IFN pathways are interrelated in the context of HPV16 infection through the upregulation of IFN-κ by TGFβ. The ability of TGFβ to induce IFN-κ promoter demethylation and transcriptional activation provides a new explanation for why HPV has evolved mechanisms to inhibit TGFβ in infected cells.

Th 17-Associated Inflammation Promotes Papilloma Development by Up-regulating γ IFN

Promotes Papilloma Development by Up-regulating Th 17-Associated Inflammation

Ifn Gamma Promotes Papilloma Development by Up-Regulating Th17-Associated Inflammation

IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor Cells

Ifn-Gamma-Mediated Downregulation Of Lxa4 Is Necessary For The Maintenance Of Nonresolving Inflammation And Papilloma Persistence

Hmgb1-IL-23-IL-17-IL-6-Stat3 Axis Promotes Tumor Growth in Murine Models of Melanoma

Induction of Interferon Kappa in Human Papillomavirus 16 Infection by Transforming Growth Factor Beta-Induced Promoter Demethylation

Th2 Type Inflammation Promotes the Gradual Progression of HPV-infected Cervical Cells to Cervical Carcinoma

Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity

Augmenting antitumor efficacy of Th17-derived Th1 cells through IFN-γ-induced type I interferon response network via IRF7

Up-Regulation Of Th17 Cells May Underlie Inhibition Of Treg Development Caused By Immunization With Activated Syngeneic T Cells

Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2.

Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand-1 surface expression.

Th17 and Th17-stimulated CD8⁺ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity.

[Antitumor effect of mIFN-λ3 in C57BL/6 mice model for papilloma tumors]

IFN-γ Induces Epithelial-to-mesenchymal Transition of Cancer Cells Via an Unique Microrna Processing

Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment

Tumor Microenvironment Macrophage Inhibitory Factor Directs the Accumulation of Interleukin-17-producing Tumor-Infiltrating Lymphocytes and Predicts Favorable Survival in Nasopharyngeal Carcinoma Patients.

IFI16 Promotes Cervical Cancer Progression by Upregulating PD-L1 in Immunomicroenvironment Through STING-TBK1-NF-kB Pathway.

Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development

Interleukin 10 Promotes Immune Response by Increasing the Survival of Activated CD8+ T Cells in Human Papillomavirus 16-Infected Cervical Cancer